223 related articles for article (PubMed ID: 32129945)
1. Potent USP10/13 antagonist spautin-1 suppresses melanoma growth via ROS-mediated DNA damage and exhibits synergy with cisplatin.
Guo J; Zhang J; Liang L; Liu N; Qi M; Zhao S; Su J; Liu J; Peng C; Chen X; Liu H
J Cell Mol Med; 2020 Apr; 24(7):4324-4340. PubMed ID: 32129945
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer.
Liao Y; Guo Z; Xia X; Liu Y; Huang C; Jiang L; Wang X; Liu J; Huang H
J Exp Clin Cancer Res; 2019 Apr; 38(1):157. PubMed ID: 30975171
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ubiquitin-specific protease 13-mediated degradation of Raf1 kinase by Spautin-1 has opposing effects in naïve and primed pluripotent stem cells.
Wang X; Wang X; Zhang X; Zhang Y; Zhu Z; Li Y; Zhang M; Ji J; Yu Y; Ye SD
J Biol Chem; 2021 Nov; 297(5):101332. PubMed ID: 34688658
[TBL] [Abstract][Full Text] [Related]
4. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13.
Liu J; Xia H; Kim M; Xu L; Li Y; Zhang L; Cai Y; Norberg HV; Zhang T; Furuya T; Jin M; Zhu Z; Wang H; Yu J; Li Y; Hao Y; Choi A; Ke H; Ma D; Yuan J
Cell; 2011 Sep; 147(1):223-34. PubMed ID: 21962518
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
[TBL] [Abstract][Full Text] [Related]
6. RNAi Screening-based Identification of USP10 as a Novel Regulator of Paraptosis.
Kim JY; Lee DM; Woo HG; Kim KD; Lee HJ; Kwon YJ; Choi KS
Sci Rep; 2019 Mar; 9(1):4909. PubMed ID: 30894572
[TBL] [Abstract][Full Text] [Related]
7. EphB4 inhibitor overcome the acquired resistance to cisplatin in melanomas xenograft model.
Yang X; Yang Y; Tang S; Tang H; Yang G; Xu Q; Wu J
J Pharmacol Sci; 2015 Sep; 129(1):65-71. PubMed ID: 26390965
[TBL] [Abstract][Full Text] [Related]
8. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.
Arienti C; Zoli W; Pignatta S; Carloni S; Paganelli G; Ulivi P; Romeo A; Menghi E; Sarnelli A; Medri L; Polico R; Silvestrini R; Tesei A
J Cell Physiol; 2014 Oct; 229(10):1548-56. PubMed ID: 24591063
[TBL] [Abstract][Full Text] [Related]
10. Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin.
Li N; Liu Y; Pang H; Lee D; Zhou Y; Xiao Z
Med Sci Monit; 2019 Mar; 25():1590-1599. PubMed ID: 30821276
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationship (SAR) Study of Spautin-1 to Entail the Discovery of Novel NEK4 Inhibitors.
Elsocht M; Giron P; Maes L; Versées W; Gutierrez GJ; De Grève J; Ballet S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435251
[TBL] [Abstract][Full Text] [Related]
12. Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ζ.
Song L; McNeil EM; Ritchie AM; Astell KR; Gourley C; Melton DW
BMC Cancer; 2017 Dec; 17(1):864. PubMed ID: 29254481
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies.
Didier R; Mallavialle A; Ben Jouira R; Domdom MA; Tichet M; Auberger P; Luciano F; Ohanna M; Tartare-Deckert S; Deckert M
Mol Cancer Ther; 2018 Jul; 17(7):1416-1429. PubMed ID: 29703842
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells.
Montagnani Marelli M; Marzagalli M; Moretti RM; Beretta G; Casati L; Comitato R; Gravina GL; Festuccia C; Limonta P
Sci Rep; 2016 Jul; 6():30502. PubMed ID: 27461002
[TBL] [Abstract][Full Text] [Related]
15. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
16. RJT-101, a novel camptothecin derivative, is highly effective in the treatment of melanoma through DNA damage by targeting topoisomerase 1.
Lian C; Cao S; Zeng W; Li Y; Su J; Li J; Zhao S; Wu L; Tao J; Zhou J; Chen X; Peng C
Biochem Pharmacol; 2020 Jan; 171():113716. PubMed ID: 31751535
[TBL] [Abstract][Full Text] [Related]
17. Fasting boosts sensitivity of human skin melanoma to cisplatin-induced cell death.
Antunes F; Corazzari M; Pereira G; Fimia GM; Piacentini M; Smaili S
Biochem Biophys Res Commun; 2017 Mar; 485(1):16-22. PubMed ID: 27693581
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis.
Faller WJ; Rafferty M; Hegarty S; Gremel G; Ryan D; Fraga MF; Esteller M; Dervan PA; Gallagher WM
Melanoma Res; 2010 Oct; 20(5):392-400. PubMed ID: 20848733
[TBL] [Abstract][Full Text] [Related]
19. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
Yang BF; Xiao C; Li H; Yang SJ
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
[TBL] [Abstract][Full Text] [Related]
20. Spautin-A41 Attenuates Cerulein-Induced Acute Pancreatitis through Inhibition of Dysregulated Autophagy.
Dong K; Chen X; Xie L; Yu L; Shen M; Wang Y; Wu S; Wang J; Lu J; Wei G; Xu D; Yang L
Biol Pharm Bull; 2019; 42(11):1789-1798. PubMed ID: 31685763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
